Michael J Properzi1, Rachel F Buckley2, Jasmeer P Chhatwal3, Michael C Donohue4, Cristina Lois5, Elizabeth C Mormino6, Keith A Johnson7, Reisa A Sperling3, Aaron P Schultz8. 1. Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. 2. Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; The Florey Institute, The University of Melbourne, Victoria, Australia; Melbourne School of Psychological Sciences, University of Melbourne, Victoria, Australia. 3. Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA. 4. Alzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California, San Diego, CA, USA. 5. Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA. 6. Department of Neurology, Stanford University, CA, USA. 7. Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA. 8. Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA. Electronic address: aschultz@nmr.mgh.harvard.edu.
Abstract
INTRODUCTION: There is a growing need in clinical research domains for direct comparability between amyloid-beta (Aβ) Positron Emission Tomography (PET) measures obtained via different radiotracers and processing methodologies. Previous efforts to provide a common measurement scale fail to account for non-linearities between measurement scales that can arise from these differences. We introduce a new application of distribution mapping, based on well established statistical orthodoxy, that we call Nonlinear Distribution Mapping (NoDiM). NoDiM uses cumulative distribution functions to derive mappings between Aβ-PET measurements from different tracers and processing streams that align data based on their location in their respective distributions. METHODS: Utilizing large datasets of Florbetapir (FBP) from the Alzheimer's Disease Neuroimaging Initiative (n = 349 female (%) = 53) and Pittsburgh Compound B (PiB) from the Harvard Aging Brain Study (n = 305 female (%) = 59.3) and the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (n = 184 female (%) = 53.3), we fit explicit mathematical models of a mixture of two normal distributions, with parameter estimates from Gaussian Mixture Models, to each tracer's empirical data. We demonstrate the accuracy of these fits, and then show the ability of NoDiM to transform FBP measurements into PiB-like units. RESULTS: A mixture of two normal distributions fit both the FBP and PiB empirical data and provides a strong basis for derivation of a transfer function. Transforming Aβ-PET data with NoDiM results in FBP and PiB distributions that are closely aligned throughout their entire range, while a linear transformation does not. Additionally the NoDiM transform better matches true positive and false positive profiles across tracers. DISCUSSION: The NoDiM transformation provides a useful alternative to the linear mapping advocated in the Centiloid project, and provides improved correspondence between measurements from different tracers across the range of observed values. This improved alignment enables disparate measures to be merged on to continuous scale, and better enables the use of uniform thresholds across tracers.
INTRODUCTION: There is a growing need in clinical research domains for direct comparability between amyloid-beta (Aβ) Positron Emission Tomography (PET) measures obtained via different radiotracers and processing methodologies. Previous efforts to provide a common measurement scale fail to account for non-linearities between measurement scales that can arise from these differences. We introduce a new application of distribution mapping, based on well established statistical orthodoxy, that we call Nonlinear Distribution Mapping (NoDiM). NoDiM uses cumulative distribution functions to derive mappings between Aβ-PET measurements from different tracers and processing streams that align data based on their location in their respective distributions. METHODS: Utilizing large datasets of Florbetapir (FBP) from the Alzheimer's Disease Neuroimaging Initiative (n = 349 female (%) = 53) and Pittsburgh Compound B (PiB) from the Harvard Aging Brain Study (n = 305 female (%) = 59.3) and the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (n = 184 female (%) = 53.3), we fit explicit mathematical models of a mixture of two normal distributions, with parameter estimates from Gaussian Mixture Models, to each tracer's empirical data. We demonstrate the accuracy of these fits, and then show the ability of NoDiM to transform FBP measurements into PiB-like units. RESULTS: A mixture of two normal distributions fit both the FBP and PiB empirical data and provides a strong basis for derivation of a transfer function. Transforming Aβ-PET data with NoDiM results in FBP and PiB distributions that are closely aligned throughout their entire range, while a linear transformation does not. Additionally the NoDiM transform better matches true positive and false positive profiles across tracers. DISCUSSION: The NoDiM transformation provides a useful alternative to the linear mapping advocated in the Centiloid project, and provides improved correspondence between measurements from different tracers across the range of observed values. This improved alignment enables disparate measures to be merged on to continuous scale, and better enables the use of uniform thresholds across tracers.
Authors: Douglas N Greve; David H Salat; Spencer L Bowen; David Izquierdo-Garcia; Aaron P Schultz; Ciprian Catana; J Alex Becker; Claus Svarer; Gitte M Knudsen; Reisa A Sperling; Keith A Johnson Journal: Neuroimage Date: 2016-02-23 Impact factor: 6.556
Authors: Susan M Landau; Christopher Breault; Abhinay D Joshi; Michael Pontecorvo; Chester A Mathis; William J Jagust; Mark A Mintun Journal: J Nucl Med Date: 2012-11-19 Impact factor: 10.057
Authors: R S Desikan; L K McEvoy; D Holland; W K Thompson; J B Brewer; P S Aisen; O A Andreassen; B T Hyman; R A Sperling; A M Dale Journal: AJNR Am J Neuroradiol Date: 2012-09-13 Impact factor: 3.825
Authors: Christopher C Rowe; Svetlana Pejoska; Rachel S Mulligan; Gareth Jones; J Gordon Chan; Samuel Svensson; Zsolt Cselényi; Colin L Masters; Victor L Villemagne Journal: J Nucl Med Date: 2013-04-10 Impact factor: 10.057
Authors: Rik Vandenberghe; Koen Van Laere; Adrian Ivanoiu; Eric Salmon; Christine Bastin; Eric Triau; Steen Hasselbalch; Ian Law; Allan Andersen; Alex Korner; Lennart Minthon; Gaëtan Garraux; Natalie Nelissen; Guy Bormans; Chris Buckley; Rikard Owenius; Lennart Thurfjell; Gill Farrar; David J Brooks Journal: Ann Neurol Date: 2010-09 Impact factor: 10.422
Authors: William E Klunk; Robert A Koeppe; Julie C Price; Tammie L Benzinger; Michael D Devous; William J Jagust; Keith A Johnson; Chester A Mathis; Davneet Minhas; Michael J Pontecorvo; Christopher C Rowe; Daniel M Skovronsky; Mark A Mintun Journal: Alzheimers Dement Date: 2014-10-28 Impact factor: 21.566
Authors: Christopher C Rowe; Uwe Ackerman; William Browne; Rachel Mulligan; Kerryn L Pike; Graeme O'Keefe; Henry Tochon-Danguy; Gordon Chan; Salvatore U Berlangieri; Gareth Jones; Kerryn L Dickinson-Rowe; Hank P Kung; Wei Zhang; Mei Ping Kung; Daniel Skovronsky; Thomas Dyrks; Gerhard Holl; Sabine Krause; Matthias Friebe; Lutz Lehman; Stefanie Lindemann; Ludger M Dinkelborg; Colin L Masters; Victor L Villemagne Journal: Lancet Neurol Date: 2008-01-10 Impact factor: 44.182
Authors: Rachel F Buckley; Aaron P Schultz; Trey Hedden; Kathryn V Papp; Bernard J Hanseeuw; Gad Marshall; Jorge Sepulcre; Emily E Smith; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Jasmeer P Chhatwal Journal: Neurology Date: 2017-06-07 Impact factor: 9.910
Authors: Christopher C Rowe; Vincent Doré; Gareth Jones; David Baxendale; Rachel S Mulligan; Santiago Bullich; Andrew W Stephens; Susan De Santi; Colin L Masters; Ludger Dinkelborg; Victor L Villemagne Journal: Eur J Nucl Med Mol Imaging Date: 2017-06-22 Impact factor: 9.236
Authors: Yi Su; Shaney Flores; Russ C Hornbeck; Benjamin Speidel; Andrei G Vlassenko; Brian A Gordon; Robert A Koeppe; William E Klunk; Chengjie Xiong; John C Morris; Tammie L S Benzinger Journal: Neuroimage Clin Date: 2018-04-25 Impact factor: 4.881
Authors: Michelle E Farrell; Kathryn V Papp; Rachel F Buckley; Heidi I L Jacobs; Aaron P Schultz; Michael J Properzi; Patrizia Vannini; Bernard J Hanseeuw; Dorene M Rentz; Keith A Johnson; Reisa A Sperling Journal: Neurology Date: 2022-03-25 Impact factor: 11.800
Authors: Huntington Potter; Jonathan H Woodcock; Timothy D Boyd; Christina M Coughlan; John R O'Shaughnessy; Manuel T Borges; Ashesh A Thaker; Balaibail A Raj; Katarzyna Adamszuk; David Scott; Vanesa Adame; Paige Anton; Heidi J Chial; Helen Gray; Joseph Daniels; Michelle E Stocker; Stefan H Sillau Journal: Alzheimers Dement (N Y) Date: 2021-03-24
Authors: Mabel Seto; Emily R Mahoney; Logan Dumitrescu; Vijay K Ramanan; Corinne D Engelman; Yuetiva Deming; Marilyn Albert; Sterling C Johnson; Henrik Zetterberg; Kaj Blennow; Prashanthi Vemuri; Angela L Jefferson; Timothy J Hohman Journal: Brain Commun Date: 2022-03-17
Authors: Jaclyn M Eissman; Logan Dumitrescu; Emily R Mahoney; Alexandra N Smith; Shubhabrata Mukherjee; Michael L Lee; Phoebe Scollard; Seo Eun Choi; William S Bush; Corinne D Engelman; Qiongshi Lu; David W Fardo; Emily H Trittschuh; Jesse Mez; Catherine C Kaczorowski; Hector Hernandez Saucedo; Keith F Widaman; Rachel F Buckley; Michael J Properzi; Elizabeth C Mormino; Hyun Sik Yang; Theresa M Harrison; Trey Hedden; Kwangsik Nho; Shea J Andrews; Douglas Tommet; Niran Hadad; R Elizabeth Sanders; Douglas M Ruderfer; Katherine A Gifford; Xiaoyuan Zhong; Neha S Raghavan; Badri N Vardarajan; Margaret A Pericak-Vance; Lindsay A Farrer; Li San Wang; Carlos Cruchaga; Gerard D Schellenberg; Nancy J Cox; Jonathan L Haines; C Dirk Keene; Andrew J Saykin; Eric B Larson; Reisa A Sperling; Richard Mayeux; Michael L Cuccaro; David A Bennett; Julie A Schneider; Paul K Crane; Angela L Jefferson; Timothy J Hohman Journal: Brain Date: 2022-07-29 Impact factor: 15.255
Authors: Michelle E Farrell; Shu Jiang; Aaron P Schultz; Michael J Properzi; Julie C Price; J Alex Becker; Heidi I L Jacobs; Bernard J Hanseeuw; Dorene M Rentz; Victor L Villemagne; Kathryn V Papp; Elizabeth C Mormino; Rebecca A Betensky; Keith A Johnson; Reisa A Sperling; Rachel F Buckley Journal: Neurology Date: 2020-11-16 Impact factor: 9.910
Authors: Logan Dumitrescu; Emily R Mahoney; Shubhabrata Mukherjee; Michael L Lee; William S Bush; Corinne D Engelman; Qiongshi Lu; David W Fardo; Emily H Trittschuh; Jesse Mez; Catherine Kaczorowski; Hector Hernandez Saucedo; Keith F Widaman; Rachel Buckley; Michael Properzi; Elizabeth Mormino; Hyun-Sik Yang; Tessa Harrison; Trey Hedden; Kwangsik Nho; Shea J Andrews; Doug Tommet; Niran Hadad; R Elizabeth Sanders; Douglas M Ruderfer; Katherine A Gifford; Annah M Moore; Francis Cambronero; Xiaoyuan Zhong; Neha S Raghavan; Badri Vardarajan; Margaret A Pericak-Vance; Lindsay A Farrer; Li-San Wang; Carlos Cruchaga; Gerard Schellenberg; Nancy J Cox; Jonathan L Haines; C Dirk Keene; Andrew J Saykin; Eric B Larson; Reisa A Sperling; Richard Mayeux; David A Bennett; Julie A Schneider; Paul K Crane; Angela L Jefferson; Timothy J Hohman Journal: Brain Date: 2020-08-01 Impact factor: 13.501